Dystonia in corticobasal degeneration: A review of the literature on 404 pathologically proven cases

Movement Disorders

Volumn 27, Issue 6, 2012, Pages 696-702

  Stamelou, Maria ^a   Alonso Canovas, Araceli ^a   Bhatia, Kailash P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Apraxia; Corticobasal degeneration; Corticobasal syndrome; Dystonia; Myoclonus

Indexed keywords

AMANTADINE; AMITRIPTYLINE; BROMOCRIPTINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; ETIRACETAM; LEVODOPA; PRIMIDONE; PROPRANOLOL; VALPROIC ACID;

AKINETIC MUTISM; ALZHEIMER DISEASE; APRAXIA; ARM; BLEPHAROSPASM; BRAIN CORTEX ATROPHY; CERVICAL DYSTONIA; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; DEMENTIA; DISEASE COURSE; DISEASE DURATION; DYSTONIA; FACE; FRONTOTEMPORAL DEMENTIA; HUMAN; LEG; MYOCLONUS DYSTONIA; NEUROPATHOLOGY; ONSET AGE; PARKINSONISM; PHENOTYPE; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; PROGRESSIVE NONFLUENT APHASIA; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SEMANTIC DEMENTIA; SYSTEMATIC REVIEW;

BASAL GANGLIA; BASAL GANGLIA DISEASES; CEREBRAL CORTEX; DYSTONIA; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 84861717261     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.24992     Document Type: Review

References (89)

1. Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989; 112: 1171-1192.
2. Rebeiz JJ, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968; 18: 20-33.
3. Boeve BF. The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study. J Mol Neurosci 2011; 45: 350-353.
4. Kouri N, Whitwell JL, Josephs KA, Rademakers R, Dickson DW. Corticobasal degeneration: a pathologically distinct 4R tauopathy. Nat Rev Neurol 2011; 7: 263-272.
5. Riley DE, Lang AE, Lewis A, et al. Cortical-basal ganglionic degeneration. Neurology 1990; 40: 1203-1212.
6. Watts RL, Mirra SS. Cortico-Basal Ganglionic Degeneration. Oxford, UK: Butterworth Heinemann; 1994.
7. Litvan I, Cummings JL, Mega M. Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiatry 1998; 65: 717-721.
8. Bak TH, Hodges JR. Corticobasal degeneration: clinical aspects. Handb Clin Neurol 2008; 89: 509-521.
9. Halpern C, McMillan C, Moore P, Dennis K, Grossman M. Calculation impairment in neurodegenerative diseases. J Neurol Sci 2003; 208: 31-38.
10. Kompoliti K, Goetz CG, Boeve BF, et al. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol 1998; 55: 957-961.
11. Vanek Z, Jankovic J. Dystonia in corticobasal degeneration. Mov Disord 2001; 16: 252-257.
12. Godeiro-Junior C, Felicio AC, Barsottini OG, et al. Clinical features of dystonia in atypical parkinsonism. Arq Neuropsiquiatr 2008; 66: 800-804.
13. Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002; 61: 935-946.
14. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain 2005; 128: 1996-2005.
15. Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006; 66: 41-48.
16. Forman MS, Farmer J, Johnson JK, et al. Frontotemporal dementia: clinicopathological correlations. Ann Neurol 2006; 59: 952-962.
17. Whitwell JL, Jack CR, Jr. Parisi JE, et al. Rates of cerebral atrophy differ in different degenerative pathologies. Brain 2007; 130: 1148-1158.
18. Geda YE, Boeve BF, Negash S, et al. Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. J Neuropsychiatry Clin Neurosci 2007; 19: 77-80.
19. Llado A, Sanchez-Valle R, Rey MJ, et al. Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration. J Neurol 2008; 255: 488-494.
20. Vanvoorst WA, Greenaway MC, Boeve BF, et al. Neuropsychological findings in clinically atypical autopsy confirmed corticobasal degeneration and progressive supranuclear palsy. Parkinsonism Relat Disord 2008; 14: 376-378.
21. Josephs KA, Ahlskog JE, Parisi JE, et al. Rapidly progressive neurodegenerative dementias. Arch Neurol 2009; 66: 201-207.
22. Huey ED, Goveia EN, Paviol S, et al. Executive dysfunction in frontotemporal dementia and corticobasal syndrome. Neurology 2009; 72: 453-459.
23. Deramecourt V, Lebert F, Debachy B, et al. Prediction of pathology in primary progressive language and speech disorders. Neurology 2010; 74: 42-49.
24. Josephs KA, Tang-Wai DF, Edland SD, et al. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Arch Neurol 2004; 61: 1881-1884.
25. Josephs KA, Duffy JR. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Curr Opin Neurol 2008; 21: 688-692.
26. Graham NL, Bak T, Patterson K, Hodges JR. Language function and dysfunction in corticobasal degeneration. Neurology 2003; 61: 493-499.
27. Josephs KA, Whitwell JL, Boeve BF, et al. Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease. Mov Disord 2010; 25: 1246-1252.
28. Renner JA, Burns JM, Hou CE, McKeel DW Jr, Storandt M, Morris JC. Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology 2004; 63: 1175-1180.
29. Rohrer JD, Lashley T, Schott JM, et al. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 2011; 134: 2565-2581.
30. Schofield EC, Caine D, Kril JJ, Cordato NJ, Halliday GM. Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration. Mov Disord 2005; 20: 34-39.
31. Kurihara T, Landau WM, Torack RM. Progressive supranuclear palsy with action myoclonus, seizures. Neurology 1974; 24: 219-223.
32. Klodowska-Duda G, Slowinski J, Opala G, et al. Corticobasal degeneration -clinico-pathological considerations. Folia Neuropathol 2006; 44: 257-264.
33. Clark AW, Manz HJ, White CL3rd, Lehmann J, Miller D, Coyle JT. Cortical degeneration with swollen chromatolytic neurons: its relationship to Pick's disease. J Neuropathol Exp Neurol 1986; 45: 268-284.
34. Greene PE, Fahn S, Lang AE, Watts RL, Eidelberg D, Powers JM. What is it? Case 1, 1990: progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to fixed postural deformity of the involved limb. Mov Disord 1990; 5: 341-351.
35. Lippa CF, Smith TW, Fontneau N. Corticonigral degeneration with neuronal achromasia. A clinicopathologic study of two cases. J Neurol Sci 1990; 98: 301-310.
36. Mori H, Nishimura M, Namba Y, Oda M. Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol 1994; 88: 113-121.
37. Paulus W, Selim M. Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol 1990; 81: 89-94.
38. Mitani K, Uchihara T, Tamaru F, Endo K, Tsukagoshi H. [Corticobasal degeneration: clinico-pathological studies on two cases]. Rinsho Shinkeigaku 1993; 33: 155-161.
39. Tsuchiya K, Murayama S, Mitani K, et al. Constant and severe involvement of Betz cells in corticobasal degeneration is not consistent with pyramidal signs: a clinicopathological study of ten autopsy cases. Acta Neuropathol 2005; 109: 353-366.
40. Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration. A clinical study of 36 cases. Brain 1994; 117: 1183-1196.
41. Horoupian DS, Chu PL. Unusual case of corticobasal degeneration with tau/Gallyas-positive neuronal and glial tangles. Acta Neuropathol 1994; 88: 592-598.
42. Oda T, Ikeda K, Akamatsu W, et al. [An autopsy case of corticobasal degeneration clinically misdiagnosed as Pick's disease]. Seishin Shinkeigaku Zasshi 1995; 97: 757-769.
43. Rey GJ, Tomer R, Levin BE, Sanchez-Ramos J, Bowen B, Bruce JH. Psychiatric symptoms, atypical dementia, and left visual field inattention in corticobasal ganglionic degeneration. Mov Disord 1995; 10: 106-110.
44. Jendroska K, Rossor MN, Mathias CJ, Daniel SE. Morphological overlap between corticobasal degeneration and Pick's disease: a clinicopathological report. Mov Disord 1995; 10: 111-114.
45. Bergeron C, Pollanen MS, Weyer L, Black SE, Lang AE. Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol 1996; 40: 893-900.
46. Takahashi T, Amano N, Hanihara T, et al. Corticobasal degeneration: widespread argentophilic threads and glia in addition to neurofibrillary tangles. Similarities of cytoskeletal abnormalities in corticobasal degeneration and progressive supranuclear palsy. J Neurol Sci 1996; 138: 66-77.
47. Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 1997; 48: 959-969.
48. Wenning GK, Litvan I, Jankovic J, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998; 64: 184-189.
49. Litvan I, Grimes DA, Lang AE, et al. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999; 246( SUPPL 2): II1-II5.
50. Hu WT, Rippon GW, Boeve BF, et al. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord 2009; 24: 1375-1379.
51. Shiozawa M, Fukutani Y, Sasaki K, et al. Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy. Clin Neuropathol 2000; 19: 192-199.
52. Tang-Wai DF, Josephs KA, Boeve BF, Dickson DW, Parisi JE, Petersen RC. Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction. Neurology 2003; 61: 1134-1135.
53. Mizuno T, Shiga K, Nakata Y, et al. Discrepancy between clinical and pathological diagnoses of CBD and PSP. J Neurol 2005; 252: 687-697.
54. Sanchez-Valle R, Forman MS, Miller BL, Gorno-Tempini ML. From progressive nonfluent aphasia to corticobasal syndrome: a case report of corticobasal degeneration. Neurocase 2006; 12: 355-359.
55. Murray R, Neumann M, Forman MS, et al. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology 2007; 68: 1274-1283.
56. Tiwari D, Amar K. A case of corticobasal degeneration presenting with alien limb syndrome. Age Ageing 2008; 37( 5): 600-601.
57. Shelley BP, Hodges JR, Kipps CM, Xuereb JH, Bak TH. Is the pathology of corticobasal syndrome predictable in life? Mov Disord 2009; 24: 1593-1599.
58. Hassan A, Whitwell JL, Boeve BF, et al. Symmetric corticobasal degeneration (S-CBD). Parkinsonism Relat Disord 2010; 16: 208-214.
59. Kouri N, Murray ME, Hassan A, et al. Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. Brain 2011; 134: 3264-3275.
60. Horvath J, Kovari E, Bouras C, Burkhard PR. Neuropathological correlates of lower limb corticobasal degeneration. Neuropathol Appl Neurobiol 2009; 35: 623-627.
61. Forman MS, Zhukareva V, Bergeron C, et al. Signature tau neuropathology in gray and white matter of corticobasal degeneration. Am J Pathol 2002; 160: 2045-2053.
62. Lee SE, Rabinovici GD, Mayo MC, et al. Clinicopathological correlations in corticobasal degeneration. Ann Neurol 2011; 70: 327-340.
63. Douglas VC, DeArmond SJ, Aminoff MJ, Miller BL, Rabinovici GD. Seizures in corticobasal degeneration: a case report. Neurocase 2009; 15: 352-356.
64. Kertesz A, Martinez-Lage P, Davidson W, Munoz DG. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 2000; 55: 1368-1375.
65. Mastrolilli F, Benvenga A, Di Biase L, et al. An unusual cause of dementia: essential diagnostic elements of corticobasal degeneration-a case report and review of the literature. Int J Alzheimers Dis 2011; 02011: 536141.
66. Iwasaki Y, Yoshida M, Hattori M, Hashizume Y, Sobue G. Widespread spinal cord involvement in corticobasal degeneration. Acta Neuropathol 2005; 109: 632-638.
67. Ling H, O'sullivan SS, Holton JL, et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 2010; 133: 2045-2057.
68. Tsuchiya K, Miyazaki H, Ikeda K, et al. Serial brain CT in corticobasal degeneration: radiological and pathological correlation of two autopsy cases. J Neurol Sci 1997; 152: 23-29.
69. Grimes DA, Lang AE, Bergeron CB. Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 1999; 53: 1969-1974.
70. Wakabayashi K, Oyanagi K, Makifuchi T, et al. Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol 1994; 87: 545-553.
71. Takao M, Tsuchiya K, Mimura M, et al. Corticobasal degeneration as cause of progressive non-fluent aphasia: clinical, radiological and pathological study of an autopsy case. Neuropathology 2006; 26: 569-578.
72. Tokumaru AM, Saito Y, Murayama S, et al. Imaging-pathologic correlation in corticobasal degeneration. AJNR Am J Neuroradiol 2009; 30: 1884-1892.
73. Pantelyat A, Dreyfuss M, Moore P, et al. Acalculia in autopsy-proven corticobasal degeneration. Neurology 2011; 76( 7 SUPPL 2): S61-S63.
74. Rankin KP, Mayo MC, Seeley WW, et al. Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: phenotypic comparison to bvFTD with Pick's disease. J Mol Neurosci 2011; 45: 594-608.
75. Ikeda K, Akiyama H, Iritani S, et al. Corticobasal degeneration with primary progressive aphasia and accentuated cortical lesion in superior temporal gyrus: case report and review. Acta Neuropathol 1996; 92: 534-539.
76. Leinonen V, Koivisto AM, Savolainen S, et al. Post-mortem findings in 10 patients with presumed normal pressure hydrocephalus and review of the literature. Neuropathol Appl Neurobiol 2012; 38: 72-86.
77. Hasselblatt M, Follinger S, Steinbach P, Schwan A, Paulus W. Corticobasal degeneration presenting with progressive spasticity. Neurology 2007; 68: 791-792.
78. Kimura N, Kumamoto T, Hanaoka T, Hazama Y, Nakamura K, Arakawa R. Corticobasal degeneration presenting with progressive conduction aphasia. J Neurol Sci 2008; 269: 163-168.
79. Snowden JS, Thompson JC, Stopford CL, et al. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. Brain 2011; 134: 2478-2492.
80. Sawle GV, Brooks DJ, Marsden CD, Frackowiak RS. Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain 1991; 114: 541-556.
81. Jung HH, Bremer J, Streffer J, et al. Phenotypic Variation of autosomal-dominant corticobasal degeneration. Eur Neurol 2012; 67: 142-150.
82. Boeve BF, Maraganore DM, Parisi JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999; 53: 795-800.
83. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997; 48: 119-125.
84. Huang KJ, Lu MK, Kao A, Tsai CH. Clinical, imaging and electrophysiological studies of corticobasal degeneration. Acta Neurol Taiwan 2007; 16: 13-21.
85. Thompson PD, Day BL, Rothwell JC, Brown P, Britton TC, Marsden CD. The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus. Brain 1994; 117: 1197-1207.
86. Lu CS, Ikeda A, Terada K, et al. Electrophysiological studies of early stage corticobasal degeneration. Mov Disord 1998; 13: 140-146.
87. Valls-Sole J, Tolosa E, Marti MJ, et al. Examination of motor output pathways in patients with corticobasal ganglionic degeneration using transcranial magnetic stimulation. Brain 2001; 124: 1131-1137.
88. Frasson E, Bertolasi L, Bertasi V, et al. Paired transcranial magnetic stimulation for the early diagnosis of corticobasal degeneration. Clin Neurophysiol 2003; 114: 272-278.
89. Muller J, Wenning GK, Wissel J, Seppi K, Poewe W. Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia. J Neurol 2002; 249: 300-304.